Polaris Pharma Group Co., Ltd.
Climate Impact & Sustainability Data (2023)
Reporting Period: 2023
Environmental Metrics
Total Carbon Emissions:2,391.74 tCO2e/year (page 64)
Total Energy Consumption:18,030.67 GJ/year (page 65)
ESG Focus Areas
- Climate Change
- Governance
- Social Responsibility
- Environmental Sustainability
Environmental Achievements
- Reduced carbon emissions by 19.56% from 2022 to 2023 (page 60)
Social Achievements
- Launched employee well-being programs (page 12)
- Increased community investment (page 12)
Governance Achievements
- Established anti-corruption training for all employees (page 34)
- Implemented policies to prevent conflicts of interest (page 34)
Climate Goals & Targets
Medium-term Goals:
- Achieve 30% renewable energy by 2025 (page 68)
Environmental Challenges
- Climate change related risks such as extreme weather events (page 62)
- Supply chain disruptions (page 62)
- Increased raw material costs (page 62)
Mitigation Strategies
- Developed alternative sourcing strategies (page 62)
- Implemented climate change adaptation solutions (page 62)
- Used low-carbon energy (page 62)
Supply Chain Management
Responsible Procurement
- Supplier sustainability requirements (page 52)
Climate-Related Risks & Opportunities
Physical Risks
- Extreme weather events (page 62)
- Typhoons and floods (page 62)
Transition Risks
- Regulatory changes (page 62)
- Carbon pricing mechanisms (page 62)
Opportunities
- Development of climate adaptation solutions (page 62)
- Transition to low-emission technologies (page 62)
Reporting Standards
Frameworks Used: GRI Standards (2021), SASB Standards, TCFD
Third-party Assurance: PwC Taiwan (page 3)